Please Wait...

Medical Imaging Analysis

In addition to serving as clinical trial endpoints, Medical Imaging can be used to monitor cardiac function in clinical trial subjects. Imaging can provide sensitive and quantitative measurements for evaluating cardiac anatomical structure, myocardial perfusion and left ventricular function, a prognostic for congenital heart disease. Bioclinica has the scientific expertise and technological capabilities to offer cardiac safety monitoring through a wide range of imaging modalities.

  • Echocardiography (ECHO)
  • Computed Tomography Angiography (CTA)
  • Cardiac Magnetic Resonance Imaging (MRI)
  • Magnetic Resonance Angiography (MRA)
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Multiple Gated Acquisition Scan (MUGA)

 

With unmatched scientific and medical expertise coupled with industry-leading technology, there is no better partner for your imaging-based clinical trial. We will work closely with you to plan the cardiac safety component of your clinical trial, from protocol development all the way through regulatory submission.

Imaging Facility Qualification

Image quality and associated data, provided within the scope of a clinical trial, can be affected by characteristic flaws of both the imaging system and software. To ensure credible data is acquired during imaging examinations, Bioclinica qualifies partner imaging sites, confirming the sites' adherence to all appropriate regulatory and professional guidelines concerning equipment calibration, testing, and maintenance.

Bioclinica provides oversight in all key areas to optimize image quality including:

  • Specification of imaging requirements
  • Review of facility imaging capabilities
  • Hardware/software assessment
  • Quantitative Phantom imaging
  • Review of facility quality control program
  • Protocol training and technical support

 

Want to learn more about how Bioclinica's medical imaging services can benefit your cardiac safety study? Contact us today!

ADDITIONAL RESOURCES

Cardiovascular Solutions

Download BROCHURE

Cardiovascular Imaging Expertise

Download OVERVIEW SHEET

Global Median Beat (GMB)

Download OVERVIEW SHEET

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

RT @lauren_chazal: OA is highly prevalent worldwide! Let's work together globally to fight OA... #orasi2017 @bioclinica https://t.co/sAofL…
bioclinica (2 days ago)
Awesome #TYCTWD in our Audubon office yesterday! Great grp of kids.Thanks all for making it a big hit & a day to r… https://t.co/gLZilvN4Wy
bioclinica (2 days ago)
[Fun Friday] When It Comes to Success, Age Really Is Just a Number Via NYT https://t.co/u82mvoYxhg
bioclinica (2 days ago)
RT @eClinical_Jen: Ron Fitzmartin of FDA states "The Reason why the FDA supports standards is to get medical products approved faster" 👍#C…
bioclinica (3 days ago)
RT @eClinical_Jen: Donate your health data to research! Check out the S4S project mentioned by @iamnotthelotus at #CDISCEurope #pharma http…
bioclinica (3 days ago)
RT @lauren_chazal: #oarsi2017 what IS the future of OA? @bioclinica https://t.co/Q9MhW8F50g
bioclinica (3 days ago)

Latest Blogs: